nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—ABCC10—Methotrexate—multiple sclerosis	0.0435	0.0747	CbGbCtD
Cyclosporine—ABCC1—Mitoxantrone—multiple sclerosis	0.0403	0.0692	CbGbCtD
Cyclosporine—ABCG2—Cladribine—multiple sclerosis	0.037	0.0635	CbGbCtD
Cyclosporine—SLCO1A2—Prednisolone—multiple sclerosis	0.0317	0.0543	CbGbCtD
Cyclosporine—SLCO1A2—Prednisone—multiple sclerosis	0.0299	0.0513	CbGbCtD
Cyclosporine—ABCB11—Dexamethasone—multiple sclerosis	0.0294	0.0505	CbGbCtD
Cyclosporine—ABCC3—Methotrexate—multiple sclerosis	0.0274	0.047	CbGbCtD
Cyclosporine—ABCG2—Mitoxantrone—multiple sclerosis	0.027	0.0463	CbGbCtD
Cyclosporine—CYP2D6—Fingolimod—multiple sclerosis	0.0195	0.0335	CbGbCtD
Cyclosporine—SLCO1A2—Dexamethasone—multiple sclerosis	0.0187	0.032	CbGbCtD
Cyclosporine—ABCC1—Methotrexate—multiple sclerosis	0.0168	0.0288	CbGbCtD
Cyclosporine—ABCC2—Dexamethasone—multiple sclerosis	0.0155	0.0266	CbGbCtD
Cyclosporine—SLCO1A2—Methotrexate—multiple sclerosis	0.015	0.0257	CbGbCtD
Cyclosporine—SLCO1B1—Methotrexate—multiple sclerosis	0.0142	0.0243	CbGbCtD
Cyclosporine—ABCG2—Dexamethasone—multiple sclerosis	0.014	0.024	CbGbCtD
Cyclosporine—ABCB1—Methylprednisolone—multiple sclerosis	0.0133	0.0229	CbGbCtD
Cyclosporine—ABCC2—Methotrexate—multiple sclerosis	0.0124	0.0213	CbGbCtD
Cyclosporine—CYP3A4—Fingolimod—multiple sclerosis	0.0124	0.0213	CbGbCtD
Cyclosporine—ABCG2—Methotrexate—multiple sclerosis	0.0112	0.0193	CbGbCtD
Cyclosporine—CYP3A7—Dexamethasone—multiple sclerosis	0.0103	0.0177	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0103	0.0177	CbGbCtD
Cyclosporine—CYP2C19—Prednisone—multiple sclerosis	0.01	0.0172	CbGbCtD
Cyclosporine—ABCB1—Mitoxantrone—multiple sclerosis	0.00973	0.0167	CbGbCtD
Cyclosporine—SLC22A6—Methotrexate—multiple sclerosis	0.0091	0.0156	CbGbCtD
Cyclosporine—ABCB1—Betamethasone—multiple sclerosis	0.00868	0.0149	CbGbCtD
Cyclosporine—ABCB1—Prednisolone—multiple sclerosis	0.00856	0.0147	CbGbCtD
Cyclosporine—ABCB1—Prednisone—multiple sclerosis	0.00808	0.0139	CbGbCtD
Cyclosporine—CYP3A4—Methylprednisolone—multiple sclerosis	0.00799	0.0137	CbGbCtD
Cyclosporine—CYP3A5—Dexamethasone—multiple sclerosis	0.00775	0.0133	CbGbCtD
Cyclosporine—CYP2C8—Dexamethasone—multiple sclerosis	0.00746	0.0128	CbGbCtD
Cyclosporine—CYP2C19—Dexamethasone—multiple sclerosis	0.00625	0.0107	CbGbCtD
Cyclosporine—PPP3CA—pons—multiple sclerosis	0.0062	0.0753	CbGeAlD
Cyclosporine—CYP3A4—Triamcinolone—multiple sclerosis	0.00606	0.0104	CbGbCtD
Cyclosporine—CYP3A4—Mitoxantrone—multiple sclerosis	0.00583	0.01	CbGbCtD
Cyclosporine—CYP2C9—Dexamethasone—multiple sclerosis	0.0052	0.00892	CbGbCtD
Cyclosporine—CYP3A4—Betamethasone—multiple sclerosis	0.0052	0.00892	CbGbCtD
Cyclosporine—CYP3A4—Prednisolone—multiple sclerosis	0.00513	0.0088	CbGbCtD
Cyclosporine—ABCB1—Dexamethasone—multiple sclerosis	0.00505	0.00866	CbGbCtD
Cyclosporine—CYP3A4—Prednisone—multiple sclerosis	0.00484	0.00831	CbGbCtD
Cyclosporine—CYP2D6—Dexamethasone—multiple sclerosis	0.00475	0.00816	CbGbCtD
Cyclosporine—ABCB1—Methotrexate—multiple sclerosis	0.00406	0.00696	CbGbCtD
Cyclosporine—CYP3A4—Dexamethasone—multiple sclerosis	0.00302	0.00519	CbGbCtD
Cyclosporine—CAMLG—brainstem—multiple sclerosis	0.00195	0.0238	CbGeAlD
Cyclosporine—PPID—retina—multiple sclerosis	0.00191	0.0232	CbGeAlD
Cyclosporine—CAMLG—retina—multiple sclerosis	0.00188	0.0229	CbGeAlD
Cyclosporine—PPIA—retina—multiple sclerosis	0.00172	0.0209	CbGeAlD
Cyclosporine—FKBP1B—nervous system—multiple sclerosis	0.0017	0.0207	CbGeAlD
Cyclosporine—FKBP1B—central nervous system—multiple sclerosis	0.00164	0.0199	CbGeAlD
Cyclosporine—FKBP1B—cerebellum—multiple sclerosis	0.0016	0.0195	CbGeAlD
Cyclosporine—PPIF—retina—multiple sclerosis	0.00139	0.0169	CbGeAlD
Cyclosporine—PPID—medulla oblongata—multiple sclerosis	0.00138	0.0168	CbGeAlD
Cyclosporine—PPP3CA—brainstem—multiple sclerosis	0.00138	0.0168	CbGeAlD
Cyclosporine—CAMLG—medulla oblongata—multiple sclerosis	0.00136	0.0166	CbGeAlD
Cyclosporine—FKBP4—spinal cord—multiple sclerosis	0.00134	0.0162	CbGeAlD
Cyclosporine—PPP3CA—retina—multiple sclerosis	0.00133	0.0162	CbGeAlD
Cyclosporine—FKBP1B—brain—multiple sclerosis	0.0013	0.0158	CbGeAlD
Cyclosporine—PPID—midbrain—multiple sclerosis	0.00126	0.0154	CbGeAlD
Cyclosporine—CAMLG—midbrain—multiple sclerosis	0.00124	0.0151	CbGeAlD
Cyclosporine—PPIA—medulla oblongata—multiple sclerosis	0.00124	0.0151	CbGeAlD
Cyclosporine—PPID—spinal cord—multiple sclerosis	0.00123	0.015	CbGeAlD
Cyclosporine—CAMLG—spinal cord—multiple sclerosis	0.00121	0.0148	CbGeAlD
Cyclosporine—PPIA—midbrain—multiple sclerosis	0.00113	0.0138	CbGeAlD
Cyclosporine—FKBP4—nervous system—multiple sclerosis	0.00112	0.0137	CbGeAlD
Cyclosporine—PPIA—spinal cord—multiple sclerosis	0.00111	0.0135	CbGeAlD
Cyclosporine—FKBP4—central nervous system—multiple sclerosis	0.00108	0.0132	CbGeAlD
Cyclosporine—FKBP4—cerebellum—multiple sclerosis	0.00106	0.0129	CbGeAlD
Cyclosporine—PPID—nervous system—multiple sclerosis	0.00104	0.0126	CbGeAlD
Cyclosporine—CAMLG—nervous system—multiple sclerosis	0.00102	0.0124	CbGeAlD
Cyclosporine—PPIF—medulla oblongata—multiple sclerosis	0.001	0.0122	CbGeAlD
Cyclosporine—PPID—central nervous system—multiple sclerosis	0.001	0.0122	CbGeAlD
Cyclosporine—CAMLG—central nervous system—multiple sclerosis	0.000985	0.012	CbGeAlD
Cyclosporine—PPID—cerebellum—multiple sclerosis	0.000977	0.0119	CbGeAlD
Cyclosporine—CAMLG—cerebellum—multiple sclerosis	0.000963	0.0117	CbGeAlD
Cyclosporine—PPP3CA—medulla oblongata—multiple sclerosis	0.000962	0.0117	CbGeAlD
Cyclosporine—PPIB—medulla oblongata—multiple sclerosis	0.000956	0.0116	CbGeAlD
Cyclosporine—PPIF—midbrain—multiple sclerosis	0.000918	0.0112	CbGeAlD
Cyclosporine—PPIF—spinal cord—multiple sclerosis	0.000896	0.0109	CbGeAlD
Cyclosporine—FKBP1A—retina—multiple sclerosis	0.000884	0.0108	CbGeAlD
Cyclosporine—PPP3CA—midbrain—multiple sclerosis	0.000879	0.0107	CbGeAlD
Cyclosporine—PPIA—cerebellum—multiple sclerosis	0.000877	0.0107	CbGeAlD
Cyclosporine—PPIB—midbrain—multiple sclerosis	0.000874	0.0106	CbGeAlD
Cyclosporine—FKBP4—brain—multiple sclerosis	0.00086	0.0105	CbGeAlD
Cyclosporine—PPP3CA—spinal cord—multiple sclerosis	0.000858	0.0104	CbGeAlD
Cyclosporine—PPIB—spinal cord—multiple sclerosis	0.000853	0.0104	CbGeAlD
Cyclosporine—PPID—brain—multiple sclerosis	0.000794	0.00965	CbGeAlD
Cyclosporine—CAMLG—brain—multiple sclerosis	0.000782	0.00951	CbGeAlD
Cyclosporine—PPIF—nervous system—multiple sclerosis	0.000755	0.00918	CbGeAlD
Cyclosporine—PPIF—central nervous system—multiple sclerosis	0.000727	0.00884	CbGeAlD
Cyclosporine—PPP3CA—nervous system—multiple sclerosis	0.000723	0.00879	CbGeAlD
Cyclosporine—PPIB—nervous system—multiple sclerosis	0.000719	0.00874	CbGeAlD
Cyclosporine—PPIA—brain—multiple sclerosis	0.000712	0.00866	CbGeAlD
Cyclosporine—PPIF—cerebellum—multiple sclerosis	0.00071	0.00864	CbGeAlD
Cyclosporine—PPP3CA—central nervous system—multiple sclerosis	0.000696	0.00846	CbGeAlD
Cyclosporine—PPIB—central nervous system—multiple sclerosis	0.000692	0.00841	CbGeAlD
Cyclosporine—PPP3CA—cerebellum—multiple sclerosis	0.00068	0.00827	CbGeAlD
Cyclosporine—PPIB—cerebellum—multiple sclerosis	0.000676	0.00822	CbGeAlD
Cyclosporine—FKBP1A—medulla oblongata—multiple sclerosis	0.000639	0.00777	CbGeAlD
Cyclosporine—SLC10A1—nervous system—multiple sclerosis	0.000615	0.00747	CbGeAlD
Cyclosporine—SLC10A1—central nervous system—multiple sclerosis	0.000592	0.00719	CbGeAlD
Cyclosporine—FKBP1A—midbrain—multiple sclerosis	0.000584	0.0071	CbGeAlD
Cyclosporine—PPIF—brain—multiple sclerosis	0.000577	0.00702	CbGeAlD
Cyclosporine—FKBP1A—spinal cord—multiple sclerosis	0.00057	0.00693	CbGeAlD
Cyclosporine—PPP3CA—brain—multiple sclerosis	0.000552	0.00672	CbGeAlD
Cyclosporine—PPIB—brain—multiple sclerosis	0.000549	0.00668	CbGeAlD
Cyclosporine—ABCC10—medulla oblongata—multiple sclerosis	0.000512	0.00623	CbGeAlD
Cyclosporine—FKBP1A—nervous system—multiple sclerosis	0.00048	0.00584	CbGeAlD
Cyclosporine—SLC10A1—brain—multiple sclerosis	0.00047	0.00571	CbGeAlD
Cyclosporine—ABCC10—midbrain—multiple sclerosis	0.000468	0.00569	CbGeAlD
Cyclosporine—FKBP1A—central nervous system—multiple sclerosis	0.000462	0.00562	CbGeAlD
Cyclosporine—ABCC10—spinal cord—multiple sclerosis	0.000457	0.00555	CbGeAlD
Cyclosporine—FKBP1A—cerebellum—multiple sclerosis	0.000452	0.00549	CbGeAlD
Cyclosporine—SLCO1A2—medulla oblongata—multiple sclerosis	0.000441	0.00537	CbGeAlD
Cyclosporine—SLC22A6—brain—multiple sclerosis	0.000404	0.00491	CbGeAlD
Cyclosporine—SLCO1A2—midbrain—multiple sclerosis	0.000403	0.0049	CbGeAlD
Cyclosporine—SLCO1A2—spinal cord—multiple sclerosis	0.000394	0.00479	CbGeAlD
Cyclosporine—ABCC3—nervous system—multiple sclerosis	0.000387	0.0047	CbGeAlD
Cyclosporine—ABCC3—central nervous system—multiple sclerosis	0.000372	0.00453	CbGeAlD
Cyclosporine—FKBP1A—brain—multiple sclerosis	0.000367	0.00446	CbGeAlD
Cyclosporine—ABCC10—cerebellum—multiple sclerosis	0.000362	0.0044	CbGeAlD
Cyclosporine—SLCO1A2—nervous system—multiple sclerosis	0.000332	0.00403	CbGeAlD
Cyclosporine—SLCO1A2—central nervous system—multiple sclerosis	0.000319	0.00388	CbGeAlD
Cyclosporine—SLCO1A2—cerebellum—multiple sclerosis	0.000312	0.00379	CbGeAlD
Cyclosporine—ABCG2—medulla oblongata—multiple sclerosis	0.0003	0.00365	CbGeAlD
Cyclosporine—ABCC3—brain—multiple sclerosis	0.000295	0.00359	CbGeAlD
Cyclosporine—CYP2D6—brainstem—multiple sclerosis	0.000295	0.00358	CbGeAlD
Cyclosporine—ABCC10—brain—multiple sclerosis	0.000294	0.00358	CbGeAlD
Cyclosporine—ABCG2—midbrain—multiple sclerosis	0.000274	0.00333	CbGeAlD
Cyclosporine—ABCG2—spinal cord—multiple sclerosis	0.000267	0.00325	CbGeAlD
Cyclosporine—ABCC1—cerebellum—multiple sclerosis	0.000256	0.00311	CbGeAlD
Cyclosporine—SLCO1A2—brain—multiple sclerosis	0.000253	0.00308	CbGeAlD
Cyclosporine—ABCG2—cerebellum—multiple sclerosis	0.000212	0.00258	CbGeAlD
Cyclosporine—ABCC1—brain—multiple sclerosis	0.000208	0.00253	CbGeAlD
Cyclosporine—ABCB1—retina—multiple sclerosis	0.000205	0.00249	CbGeAlD
Cyclosporine—CYP2C8—brain—multiple sclerosis	0.000177	0.00215	CbGeAlD
Cyclosporine—ABCG2—brain—multiple sclerosis	0.000172	0.00209	CbGeAlD
Cyclosporine—CYP3A4—nervous system—multiple sclerosis	0.000157	0.00191	CbGeAlD
Cyclosporine—CYP2D6—nervous system—multiple sclerosis	0.000154	0.00188	CbGeAlD
Cyclosporine—CYP3A4—central nervous system—multiple sclerosis	0.000151	0.00184	CbGeAlD
Cyclosporine—CYP2D6—central nervous system—multiple sclerosis	0.000149	0.00181	CbGeAlD
Cyclosporine—ABCB1—medulla oblongata—multiple sclerosis	0.000148	0.0018	CbGeAlD
Cyclosporine—CYP2D6—cerebellum—multiple sclerosis	0.000145	0.00177	CbGeAlD
Cyclosporine—ABCB1—midbrain—multiple sclerosis	0.000135	0.00164	CbGeAlD
Cyclosporine—ABCB1—spinal cord—multiple sclerosis	0.000132	0.0016	CbGeAlD
Cyclosporine—CYP2D6—brain—multiple sclerosis	0.000118	0.00144	CbGeAlD
Cyclosporine—ABCB1—nervous system—multiple sclerosis	0.000111	0.00135	CbGeAlD
Cyclosporine—ABCB1—central nervous system—multiple sclerosis	0.000107	0.0013	CbGeAlD
Cyclosporine—ABCB1—cerebellum—multiple sclerosis	0.000105	0.00127	CbGeAlD
Cyclosporine—ABCB1—brain—multiple sclerosis	8.49e-05	0.00103	CbGeAlD
Cyclosporine—Malaise—Dexamethasone—multiple sclerosis	7.69e-05	0.000346	CcSEcCtD
Cyclosporine—Malaise—Betamethasone—multiple sclerosis	7.69e-05	0.000346	CcSEcCtD
Cyclosporine—Oedema—Triamcinolone—multiple sclerosis	7.67e-05	0.000345	CcSEcCtD
Cyclosporine—Anaphylactic shock—Triamcinolone—multiple sclerosis	7.67e-05	0.000345	CcSEcCtD
Cyclosporine—Vertigo—Dexamethasone—multiple sclerosis	7.66e-05	0.000345	CcSEcCtD
Cyclosporine—Vertigo—Betamethasone—multiple sclerosis	7.66e-05	0.000345	CcSEcCtD
Cyclosporine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	7.66e-05	0.000345	CcSEcCtD
Cyclosporine—Arrhythmia—Prednisone—multiple sclerosis	7.62e-05	0.000343	CcSEcCtD
Cyclosporine—Infection—Triamcinolone—multiple sclerosis	7.62e-05	0.000343	CcSEcCtD
Cyclosporine—Infection—Methylprednisolone—multiple sclerosis	7.6e-05	0.000342	CcSEcCtD
Cyclosporine—Haematuria—Methotrexate—multiple sclerosis	7.57e-05	0.000341	CcSEcCtD
Cyclosporine—Insomnia—Prednisolone—multiple sclerosis	7.55e-05	0.00034	CcSEcCtD
Cyclosporine—Alopecia—Prednisone—multiple sclerosis	7.54e-05	0.00034	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Methotrexate—multiple sclerosis	7.51e-05	0.000338	CcSEcCtD
Cyclosporine—Nervous system disorder—Methylprednisolone—multiple sclerosis	7.51e-05	0.000338	CcSEcCtD
Cyclosporine—Epistaxis—Methotrexate—multiple sclerosis	7.49e-05	0.000337	CcSEcCtD
Cyclosporine—Hypersensitivity—Mitoxantrone—multiple sclerosis	7.49e-05	0.000337	CcSEcCtD
Cyclosporine—Paraesthesia—Prednisolone—multiple sclerosis	7.49e-05	0.000337	CcSEcCtD
Cyclosporine—Mental disorder—Prednisone—multiple sclerosis	7.48e-05	0.000337	CcSEcCtD
Cyclosporine—Nausea—Azathioprine—multiple sclerosis	7.47e-05	0.000336	CcSEcCtD
Cyclosporine—Skin disorder—Methylprednisolone—multiple sclerosis	7.44e-05	0.000335	CcSEcCtD
Cyclosporine—Malnutrition—Prednisone—multiple sclerosis	7.43e-05	0.000334	CcSEcCtD
Cyclosporine—Hyperhidrosis—Triamcinolone—multiple sclerosis	7.42e-05	0.000334	CcSEcCtD
Cyclosporine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	7.4e-05	0.000333	CcSEcCtD
Cyclosporine—Convulsion—Dexamethasone—multiple sclerosis	7.39e-05	0.000333	CcSEcCtD
Cyclosporine—Convulsion—Betamethasone—multiple sclerosis	7.39e-05	0.000333	CcSEcCtD
Cyclosporine—Hypertension—Dexamethasone—multiple sclerosis	7.36e-05	0.000332	CcSEcCtD
Cyclosporine—Hypertension—Betamethasone—multiple sclerosis	7.36e-05	0.000332	CcSEcCtD
Cyclosporine—Asthenia—Mitoxantrone—multiple sclerosis	7.3e-05	0.000329	CcSEcCtD
Cyclosporine—Myalgia—Betamethasone—multiple sclerosis	7.26e-05	0.000327	CcSEcCtD
Cyclosporine—Myalgia—Dexamethasone—multiple sclerosis	7.26e-05	0.000327	CcSEcCtD
Cyclosporine—Anxiety—Betamethasone—multiple sclerosis	7.24e-05	0.000326	CcSEcCtD
Cyclosporine—Anxiety—Dexamethasone—multiple sclerosis	7.24e-05	0.000326	CcSEcCtD
Cyclosporine—Discomfort—Dexamethasone—multiple sclerosis	7.17e-05	0.000323	CcSEcCtD
Cyclosporine—Discomfort—Betamethasone—multiple sclerosis	7.17e-05	0.000323	CcSEcCtD
Cyclosporine—Haemoglobin—Methotrexate—multiple sclerosis	7.17e-05	0.000323	CcSEcCtD
Cyclosporine—Pain—Prednisolone—multiple sclerosis	7.13e-05	0.000321	CcSEcCtD
Cyclosporine—Haemorrhage—Methotrexate—multiple sclerosis	7.13e-05	0.000321	CcSEcCtD
Cyclosporine—Hepatitis—Methotrexate—multiple sclerosis	7.13e-05	0.000321	CcSEcCtD
Cyclosporine—Pharyngitis—Methotrexate—multiple sclerosis	7.08e-05	0.000319	CcSEcCtD
Cyclosporine—Urinary tract disorder—Methotrexate—multiple sclerosis	7.04e-05	0.000317	CcSEcCtD
Cyclosporine—Vision blurred—Prednisone—multiple sclerosis	7e-05	0.000315	CcSEcCtD
Cyclosporine—Urethral disorder—Methotrexate—multiple sclerosis	6.99e-05	0.000315	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	6.99e-05	0.000315	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	6.97e-05	0.000314	CcSEcCtD
Cyclosporine—Oedema—Dexamethasone—multiple sclerosis	6.96e-05	0.000313	CcSEcCtD
Cyclosporine—Anaphylactic shock—Betamethasone—multiple sclerosis	6.96e-05	0.000313	CcSEcCtD
Cyclosporine—Oedema—Betamethasone—multiple sclerosis	6.96e-05	0.000313	CcSEcCtD
Cyclosporine—Anaphylactic shock—Dexamethasone—multiple sclerosis	6.96e-05	0.000313	CcSEcCtD
Cyclosporine—Diarrhoea—Mitoxantrone—multiple sclerosis	6.96e-05	0.000313	CcSEcCtD
Cyclosporine—Insomnia—Triamcinolone—multiple sclerosis	6.94e-05	0.000312	CcSEcCtD
Cyclosporine—Insomnia—Methylprednisolone—multiple sclerosis	6.92e-05	0.000312	CcSEcCtD
Cyclosporine—Infection—Dexamethasone—multiple sclerosis	6.92e-05	0.000311	CcSEcCtD
Cyclosporine—Infection—Betamethasone—multiple sclerosis	6.92e-05	0.000311	CcSEcCtD
Cyclosporine—Ill-defined disorder—Prednisone—multiple sclerosis	6.89e-05	0.00031	CcSEcCtD
Cyclosporine—Paraesthesia—Triamcinolone—multiple sclerosis	6.89e-05	0.00031	CcSEcCtD
Cyclosporine—Feeling abnormal—Prednisolone—multiple sclerosis	6.87e-05	0.00031	CcSEcCtD
Cyclosporine—Paraesthesia—Methylprednisolone—multiple sclerosis	6.87e-05	0.00031	CcSEcCtD
Cyclosporine—Visual impairment—Methotrexate—multiple sclerosis	6.87e-05	0.000309	CcSEcCtD
Cyclosporine—Anaemia—Prednisone—multiple sclerosis	6.87e-05	0.000309	CcSEcCtD
Cyclosporine—Dyspnoea—Triamcinolone—multiple sclerosis	6.84e-05	0.000308	CcSEcCtD
Cyclosporine—Nervous system disorder—Dexamethasone—multiple sclerosis	6.83e-05	0.000307	CcSEcCtD
Cyclosporine—Nervous system disorder—Betamethasone—multiple sclerosis	6.83e-05	0.000307	CcSEcCtD
Cyclosporine—Agitation—Prednisone—multiple sclerosis	6.83e-05	0.000307	CcSEcCtD
Cyclosporine—Thrombocytopenia—Dexamethasone—multiple sclerosis	6.82e-05	0.000307	CcSEcCtD
Cyclosporine—Thrombocytopenia—Betamethasone—multiple sclerosis	6.82e-05	0.000307	CcSEcCtD
Cyclosporine—Angioedema—Prednisone—multiple sclerosis	6.79e-05	0.000306	CcSEcCtD
Cyclosporine—Dyspepsia—Triamcinolone—multiple sclerosis	6.75e-05	0.000304	CcSEcCtD
Cyclosporine—Dyspepsia—Methylprednisolone—multiple sclerosis	6.74e-05	0.000303	CcSEcCtD
Cyclosporine—Hyperhidrosis—Dexamethasone—multiple sclerosis	6.73e-05	0.000303	CcSEcCtD
Cyclosporine—Hyperhidrosis—Betamethasone—multiple sclerosis	6.73e-05	0.000303	CcSEcCtD
Cyclosporine—Malaise—Prednisone—multiple sclerosis	6.7e-05	0.000302	CcSEcCtD
Cyclosporine—Vertigo—Prednisone—multiple sclerosis	6.67e-05	0.000301	CcSEcCtD
Cyclosporine—Tinnitus—Methotrexate—multiple sclerosis	6.65e-05	0.000299	CcSEcCtD
Cyclosporine—Anorexia—Betamethasone—multiple sclerosis	6.64e-05	0.000299	CcSEcCtD
Cyclosporine—Anorexia—Dexamethasone—multiple sclerosis	6.64e-05	0.000299	CcSEcCtD
Cyclosporine—Urticaria—Prednisolone—multiple sclerosis	6.63e-05	0.000298	CcSEcCtD
Cyclosporine—Fatigue—Triamcinolone—multiple sclerosis	6.61e-05	0.000298	CcSEcCtD
Cyclosporine—Fatigue—Methylprednisolone—multiple sclerosis	6.6e-05	0.000297	CcSEcCtD
Cyclosporine—Pain—Triamcinolone—multiple sclerosis	6.56e-05	0.000295	CcSEcCtD
Cyclosporine—Angiopathy—Methotrexate—multiple sclerosis	6.47e-05	0.000291	CcSEcCtD
Cyclosporine—Vomiting—Mitoxantrone—multiple sclerosis	6.47e-05	0.000291	CcSEcCtD
Cyclosporine—Convulsion—Prednisone—multiple sclerosis	6.44e-05	0.00029	CcSEcCtD
Cyclosporine—Mediastinal disorder—Methotrexate—multiple sclerosis	6.43e-05	0.000289	CcSEcCtD
Cyclosporine—Hypertension—Prednisone—multiple sclerosis	6.41e-05	0.000289	CcSEcCtD
Cyclosporine—Rash—Mitoxantrone—multiple sclerosis	6.41e-05	0.000289	CcSEcCtD
Cyclosporine—Dermatitis—Mitoxantrone—multiple sclerosis	6.41e-05	0.000288	CcSEcCtD
Cyclosporine—Chills—Methotrexate—multiple sclerosis	6.4e-05	0.000288	CcSEcCtD
Cyclosporine—Headache—Mitoxantrone—multiple sclerosis	6.37e-05	0.000287	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	6.34e-05	0.000286	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	6.34e-05	0.000286	CcSEcCtD
Cyclosporine—Myalgia—Prednisone—multiple sclerosis	6.32e-05	0.000285	CcSEcCtD
Cyclosporine—Arthralgia—Prednisone—multiple sclerosis	6.32e-05	0.000285	CcSEcCtD
Cyclosporine—Feeling abnormal—Triamcinolone—multiple sclerosis	6.32e-05	0.000285	CcSEcCtD
Cyclosporine—Feeling abnormal—Methylprednisolone—multiple sclerosis	6.31e-05	0.000284	CcSEcCtD
Cyclosporine—Anxiety—Prednisone—multiple sclerosis	6.3e-05	0.000284	CcSEcCtD
Cyclosporine—Alopecia—Methotrexate—multiple sclerosis	6.3e-05	0.000284	CcSEcCtD
Cyclosporine—Insomnia—Betamethasone—multiple sclerosis	6.3e-05	0.000284	CcSEcCtD
Cyclosporine—Insomnia—Dexamethasone—multiple sclerosis	6.3e-05	0.000284	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	6.28e-05	0.000283	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	6.26e-05	0.000282	CcSEcCtD
Cyclosporine—Paraesthesia—Dexamethasone—multiple sclerosis	6.25e-05	0.000281	CcSEcCtD
Cyclosporine—Paraesthesia—Betamethasone—multiple sclerosis	6.25e-05	0.000281	CcSEcCtD
Cyclosporine—Discomfort—Prednisone—multiple sclerosis	6.25e-05	0.000281	CcSEcCtD
Cyclosporine—Mental disorder—Methotrexate—multiple sclerosis	6.25e-05	0.000281	CcSEcCtD
Cyclosporine—Malnutrition—Methotrexate—multiple sclerosis	6.21e-05	0.00028	CcSEcCtD
Cyclosporine—Hypersensitivity—Prednisolone—multiple sclerosis	6.15e-05	0.000277	CcSEcCtD
Cyclosporine—Dyspepsia—Dexamethasone—multiple sclerosis	6.13e-05	0.000276	CcSEcCtD
Cyclosporine—Dyspepsia—Betamethasone—multiple sclerosis	6.13e-05	0.000276	CcSEcCtD
Cyclosporine—Urticaria—Triamcinolone—multiple sclerosis	6.09e-05	0.000274	CcSEcCtD
Cyclosporine—Urticaria—Methylprednisolone—multiple sclerosis	6.08e-05	0.000274	CcSEcCtD
Cyclosporine—Dysgeusia—Methotrexate—multiple sclerosis	6.08e-05	0.000274	CcSEcCtD
Cyclosporine—Body temperature increased—Triamcinolone—multiple sclerosis	6.06e-05	0.000273	CcSEcCtD
Cyclosporine—Oedema—Prednisone—multiple sclerosis	6.06e-05	0.000273	CcSEcCtD
Cyclosporine—Anaphylactic shock—Prednisone—multiple sclerosis	6.06e-05	0.000273	CcSEcCtD
Cyclosporine—Abdominal pain—Methylprednisolone—multiple sclerosis	6.05e-05	0.000273	CcSEcCtD
Cyclosporine—Decreased appetite—Dexamethasone—multiple sclerosis	6.05e-05	0.000273	CcSEcCtD
Cyclosporine—Decreased appetite—Betamethasone—multiple sclerosis	6.05e-05	0.000273	CcSEcCtD
Cyclosporine—Nausea—Mitoxantrone—multiple sclerosis	6.04e-05	0.000272	CcSEcCtD
Cyclosporine—Infection—Prednisone—multiple sclerosis	6.02e-05	0.000271	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	6.01e-05	0.000271	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	6.01e-05	0.000271	CcSEcCtD
Cyclosporine—Fatigue—Dexamethasone—multiple sclerosis	6e-05	0.00027	CcSEcCtD
Cyclosporine—Fatigue—Betamethasone—multiple sclerosis	6e-05	0.00027	CcSEcCtD
Cyclosporine—Pain—Dexamethasone—multiple sclerosis	5.95e-05	0.000268	CcSEcCtD
Cyclosporine—Pain—Betamethasone—multiple sclerosis	5.95e-05	0.000268	CcSEcCtD
Cyclosporine—Nervous system disorder—Prednisone—multiple sclerosis	5.95e-05	0.000268	CcSEcCtD
Cyclosporine—Skin disorder—Prednisone—multiple sclerosis	5.89e-05	0.000265	CcSEcCtD
Cyclosporine—Hyperhidrosis—Prednisone—multiple sclerosis	5.86e-05	0.000264	CcSEcCtD
Cyclosporine—Vision blurred—Methotrexate—multiple sclerosis	5.85e-05	0.000263	CcSEcCtD
Cyclosporine—Anorexia—Prednisone—multiple sclerosis	5.78e-05	0.00026	CcSEcCtD
Cyclosporine—Ill-defined disorder—Methotrexate—multiple sclerosis	5.76e-05	0.000259	CcSEcCtD
Cyclosporine—Anaemia—Methotrexate—multiple sclerosis	5.74e-05	0.000258	CcSEcCtD
Cyclosporine—Feeling abnormal—Dexamethasone—multiple sclerosis	5.74e-05	0.000258	CcSEcCtD
Cyclosporine—Feeling abnormal—Betamethasone—multiple sclerosis	5.74e-05	0.000258	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Betamethasone—multiple sclerosis	5.69e-05	0.000256	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	5.69e-05	0.000256	CcSEcCtD
Cyclosporine—Hypersensitivity—Triamcinolone—multiple sclerosis	5.65e-05	0.000255	CcSEcCtD
Cyclosporine—Hypersensitivity—Methylprednisolone—multiple sclerosis	5.64e-05	0.000254	CcSEcCtD
Cyclosporine—Malaise—Methotrexate—multiple sclerosis	5.6e-05	0.000252	CcSEcCtD
Cyclosporine—Vertigo—Methotrexate—multiple sclerosis	5.58e-05	0.000251	CcSEcCtD
Cyclosporine—Leukopenia—Methotrexate—multiple sclerosis	5.56e-05	0.00025	CcSEcCtD
Cyclosporine—Urticaria—Dexamethasone—multiple sclerosis	5.53e-05	0.000249	CcSEcCtD
Cyclosporine—Urticaria—Betamethasone—multiple sclerosis	5.53e-05	0.000249	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	5.52e-05	0.000249	CcSEcCtD
Cyclosporine—Dizziness—Prednisolone—multiple sclerosis	5.52e-05	0.000248	CcSEcCtD
Cyclosporine—Asthenia—Triamcinolone—multiple sclerosis	5.5e-05	0.000248	CcSEcCtD
Cyclosporine—Body temperature increased—Betamethasone—multiple sclerosis	5.5e-05	0.000248	CcSEcCtD
Cyclosporine—Abdominal pain—Dexamethasone—multiple sclerosis	5.5e-05	0.000248	CcSEcCtD
Cyclosporine—Abdominal pain—Betamethasone—multiple sclerosis	5.5e-05	0.000248	CcSEcCtD
Cyclosporine—Body temperature increased—Dexamethasone—multiple sclerosis	5.5e-05	0.000248	CcSEcCtD
Cyclosporine—Asthenia—Methylprednisolone—multiple sclerosis	5.49e-05	0.000247	CcSEcCtD
Cyclosporine—Insomnia—Prednisone—multiple sclerosis	5.48e-05	0.000247	CcSEcCtD
Cyclosporine—Paraesthesia—Prednisone—multiple sclerosis	5.44e-05	0.000245	CcSEcCtD
Cyclosporine—Pruritus—Triamcinolone—multiple sclerosis	5.43e-05	0.000244	CcSEcCtD
Cyclosporine—Cough—Methotrexate—multiple sclerosis	5.42e-05	0.000244	CcSEcCtD
Cyclosporine—Pruritus—Methylprednisolone—multiple sclerosis	5.42e-05	0.000244	CcSEcCtD
Cyclosporine—Convulsion—Methotrexate—multiple sclerosis	5.38e-05	0.000242	CcSEcCtD
Cyclosporine—Dyspepsia—Prednisone—multiple sclerosis	5.34e-05	0.00024	CcSEcCtD
Cyclosporine—Myalgia—Methotrexate—multiple sclerosis	5.29e-05	0.000238	CcSEcCtD
Cyclosporine—Chest pain—Methotrexate—multiple sclerosis	5.29e-05	0.000238	CcSEcCtD
Cyclosporine—Arthralgia—Methotrexate—multiple sclerosis	5.29e-05	0.000238	CcSEcCtD
Cyclosporine—Decreased appetite—Prednisone—multiple sclerosis	5.27e-05	0.000237	CcSEcCtD
Cyclosporine—Rash—Prednisolone—multiple sclerosis	5.26e-05	0.000237	CcSEcCtD
Cyclosporine—Dermatitis—Prednisolone—multiple sclerosis	5.26e-05	0.000237	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	5.25e-05	0.000236	CcSEcCtD
Cyclosporine—Diarrhoea—Methylprednisolone—multiple sclerosis	5.24e-05	0.000236	CcSEcCtD
Cyclosporine—Fatigue—Prednisone—multiple sclerosis	5.23e-05	0.000235	CcSEcCtD
Cyclosporine—Headache—Prednisolone—multiple sclerosis	5.23e-05	0.000235	CcSEcCtD
Cyclosporine—Discomfort—Methotrexate—multiple sclerosis	5.22e-05	0.000235	CcSEcCtD
Cyclosporine—Constipation—Prednisone—multiple sclerosis	5.18e-05	0.000233	CcSEcCtD
Cyclosporine—Confusional state—Methotrexate—multiple sclerosis	5.11e-05	0.00023	CcSEcCtD
Cyclosporine—Dizziness—Triamcinolone—multiple sclerosis	5.07e-05	0.000228	CcSEcCtD
Cyclosporine—Anaphylactic shock—Methotrexate—multiple sclerosis	5.07e-05	0.000228	CcSEcCtD
Cyclosporine—Dizziness—Methylprednisolone—multiple sclerosis	5.06e-05	0.000228	CcSEcCtD
Cyclosporine—Infection—Methotrexate—multiple sclerosis	5.03e-05	0.000227	CcSEcCtD
Cyclosporine—Feeling abnormal—Prednisone—multiple sclerosis	5e-05	0.000225	CcSEcCtD
Cyclosporine—Asthenia—Betamethasone—multiple sclerosis	4.99e-05	0.000225	CcSEcCtD
Cyclosporine—Asthenia—Dexamethasone—multiple sclerosis	4.99e-05	0.000225	CcSEcCtD
Cyclosporine—Nervous system disorder—Methotrexate—multiple sclerosis	4.97e-05	0.000224	CcSEcCtD
Cyclosporine—Thrombocytopenia—Methotrexate—multiple sclerosis	4.96e-05	0.000223	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Prednisone—multiple sclerosis	4.96e-05	0.000223	CcSEcCtD
Cyclosporine—Nausea—Prednisolone—multiple sclerosis	4.96e-05	0.000223	CcSEcCtD
Cyclosporine—Pruritus—Dexamethasone—multiple sclerosis	4.93e-05	0.000222	CcSEcCtD
Cyclosporine—Pruritus—Betamethasone—multiple sclerosis	4.93e-05	0.000222	CcSEcCtD
Cyclosporine—Skin disorder—Methotrexate—multiple sclerosis	4.92e-05	0.000222	CcSEcCtD
Cyclosporine—Hyperhidrosis—Methotrexate—multiple sclerosis	4.9e-05	0.000221	CcSEcCtD
Cyclosporine—Vomiting—Triamcinolone—multiple sclerosis	4.88e-05	0.00022	CcSEcCtD
Cyclosporine—Vomiting—Methylprednisolone—multiple sclerosis	4.87e-05	0.000219	CcSEcCtD
Cyclosporine—Rash—Triamcinolone—multiple sclerosis	4.84e-05	0.000218	CcSEcCtD
Cyclosporine—Dermatitis—Triamcinolone—multiple sclerosis	4.83e-05	0.000218	CcSEcCtD
Cyclosporine—Anorexia—Methotrexate—multiple sclerosis	4.83e-05	0.000217	CcSEcCtD
Cyclosporine—Rash—Methylprednisolone—multiple sclerosis	4.83e-05	0.000217	CcSEcCtD
Cyclosporine—Dermatitis—Methylprednisolone—multiple sclerosis	4.82e-05	0.000217	CcSEcCtD
Cyclosporine—Urticaria—Prednisone—multiple sclerosis	4.82e-05	0.000217	CcSEcCtD
Cyclosporine—Headache—Triamcinolone—multiple sclerosis	4.81e-05	0.000216	CcSEcCtD
Cyclosporine—Headache—Methylprednisolone—multiple sclerosis	4.8e-05	0.000216	CcSEcCtD
Cyclosporine—Abdominal pain—Prednisone—multiple sclerosis	4.79e-05	0.000216	CcSEcCtD
Cyclosporine—Body temperature increased—Prednisone—multiple sclerosis	4.79e-05	0.000216	CcSEcCtD
Cyclosporine—Diarrhoea—Dexamethasone—multiple sclerosis	4.76e-05	0.000214	CcSEcCtD
Cyclosporine—Diarrhoea—Betamethasone—multiple sclerosis	4.76e-05	0.000214	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	4.62e-05	0.000208	CcSEcCtD
Cyclosporine—Dizziness—Dexamethasone—multiple sclerosis	4.6e-05	0.000207	CcSEcCtD
Cyclosporine—Dizziness—Betamethasone—multiple sclerosis	4.6e-05	0.000207	CcSEcCtD
Cyclosporine—Insomnia—Methotrexate—multiple sclerosis	4.58e-05	0.000206	CcSEcCtD
Cyclosporine—Nausea—Triamcinolone—multiple sclerosis	4.56e-05	0.000205	CcSEcCtD
Cyclosporine—Paraesthesia—Methotrexate—multiple sclerosis	4.55e-05	0.000205	CcSEcCtD
Cyclosporine—Nausea—Methylprednisolone—multiple sclerosis	4.55e-05	0.000205	CcSEcCtD
Cyclosporine—Dyspnoea—Methotrexate—multiple sclerosis	4.52e-05	0.000203	CcSEcCtD
Cyclosporine—Somnolence—Methotrexate—multiple sclerosis	4.5e-05	0.000203	CcSEcCtD
Cyclosporine—Hypersensitivity—Prednisone—multiple sclerosis	4.47e-05	0.000201	CcSEcCtD
Cyclosporine—Dyspepsia—Methotrexate—multiple sclerosis	4.46e-05	0.000201	CcSEcCtD
Cyclosporine—Vomiting—Betamethasone—multiple sclerosis	4.43e-05	0.000199	CcSEcCtD
Cyclosporine—Vomiting—Dexamethasone—multiple sclerosis	4.43e-05	0.000199	CcSEcCtD
Cyclosporine—Decreased appetite—Methotrexate—multiple sclerosis	4.4e-05	0.000198	CcSEcCtD
Cyclosporine—Rash—Betamethasone—multiple sclerosis	4.39e-05	0.000198	CcSEcCtD
Cyclosporine—Rash—Dexamethasone—multiple sclerosis	4.39e-05	0.000198	CcSEcCtD
Cyclosporine—Dermatitis—Betamethasone—multiple sclerosis	4.39e-05	0.000197	CcSEcCtD
Cyclosporine—Dermatitis—Dexamethasone—multiple sclerosis	4.39e-05	0.000197	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	4.37e-05	0.000197	CcSEcCtD
Cyclosporine—Fatigue—Methotrexate—multiple sclerosis	4.37e-05	0.000197	CcSEcCtD
Cyclosporine—Headache—Dexamethasone—multiple sclerosis	4.36e-05	0.000196	CcSEcCtD
Cyclosporine—Headache—Betamethasone—multiple sclerosis	4.36e-05	0.000196	CcSEcCtD
Cyclosporine—Asthenia—Prednisone—multiple sclerosis	4.35e-05	0.000196	CcSEcCtD
Cyclosporine—Pain—Methotrexate—multiple sclerosis	4.33e-05	0.000195	CcSEcCtD
Cyclosporine—Pruritus—Prednisone—multiple sclerosis	4.29e-05	0.000193	CcSEcCtD
Cyclosporine—Feeling abnormal—Methotrexate—multiple sclerosis	4.18e-05	0.000188	CcSEcCtD
Cyclosporine—Diarrhoea—Prednisone—multiple sclerosis	4.15e-05	0.000187	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Methotrexate—multiple sclerosis	4.14e-05	0.000187	CcSEcCtD
Cyclosporine—Nausea—Dexamethasone—multiple sclerosis	4.13e-05	0.000186	CcSEcCtD
Cyclosporine—Nausea—Betamethasone—multiple sclerosis	4.13e-05	0.000186	CcSEcCtD
Cyclosporine—Urticaria—Methotrexate—multiple sclerosis	4.02e-05	0.000181	CcSEcCtD
Cyclosporine—Dizziness—Prednisone—multiple sclerosis	4.01e-05	0.000181	CcSEcCtD
Cyclosporine—Abdominal pain—Methotrexate—multiple sclerosis	4.01e-05	0.00018	CcSEcCtD
Cyclosporine—Body temperature increased—Methotrexate—multiple sclerosis	4.01e-05	0.00018	CcSEcCtD
Cyclosporine—Vomiting—Prednisone—multiple sclerosis	3.85e-05	0.000174	CcSEcCtD
Cyclosporine—Rash—Prednisone—multiple sclerosis	3.82e-05	0.000172	CcSEcCtD
Cyclosporine—Dermatitis—Prednisone—multiple sclerosis	3.82e-05	0.000172	CcSEcCtD
Cyclosporine—Headache—Prednisone—multiple sclerosis	3.8e-05	0.000171	CcSEcCtD
Cyclosporine—Hypersensitivity—Methotrexate—multiple sclerosis	3.73e-05	0.000168	CcSEcCtD
Cyclosporine—Asthenia—Methotrexate—multiple sclerosis	3.64e-05	0.000164	CcSEcCtD
Cyclosporine—Nausea—Prednisone—multiple sclerosis	3.6e-05	0.000162	CcSEcCtD
Cyclosporine—Pruritus—Methotrexate—multiple sclerosis	3.58e-05	0.000161	CcSEcCtD
Cyclosporine—Diarrhoea—Methotrexate—multiple sclerosis	3.47e-05	0.000156	CcSEcCtD
Cyclosporine—Dizziness—Methotrexate—multiple sclerosis	3.35e-05	0.000151	CcSEcCtD
Cyclosporine—Vomiting—Methotrexate—multiple sclerosis	3.22e-05	0.000145	CcSEcCtD
Cyclosporine—Rash—Methotrexate—multiple sclerosis	3.19e-05	0.000144	CcSEcCtD
Cyclosporine—Dermatitis—Methotrexate—multiple sclerosis	3.19e-05	0.000144	CcSEcCtD
Cyclosporine—Headache—Methotrexate—multiple sclerosis	3.17e-05	0.000143	CcSEcCtD
Cyclosporine—Nausea—Methotrexate—multiple sclerosis	3.01e-05	0.000136	CcSEcCtD
Cyclosporine—PPP3CA—Disease—APOE—multiple sclerosis	2.28e-05	0.000202	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—CCL2—multiple sclerosis	2.27e-05	0.000202	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—POMC—multiple sclerosis	2.27e-05	0.000201	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CXCL10—multiple sclerosis	2.26e-05	0.000201	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.25e-05	0.0002	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PTGER4—multiple sclerosis	2.25e-05	0.000199	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—CD80—multiple sclerosis	2.23e-05	0.000198	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—SRM—multiple sclerosis	2.23e-05	0.000198	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PGR—multiple sclerosis	2.22e-05	0.000196	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—CD86—multiple sclerosis	2.19e-05	0.000194	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—RRM1—multiple sclerosis	2.18e-05	0.000194	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CXCR3—multiple sclerosis	2.17e-05	0.000193	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.16e-05	0.000192	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CD28—multiple sclerosis	2.15e-05	0.000191	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CCR2—multiple sclerosis	2.11e-05	0.000187	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	2.1e-05	0.000186	CbGpPWpGaD
Cyclosporine—PPIA—Disease—TYK2—multiple sclerosis	2.1e-05	0.000186	CbGpPWpGaD
Cyclosporine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.09e-05	0.000185	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—RRM1—multiple sclerosis	2.07e-05	0.000184	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—ALB—multiple sclerosis	2.07e-05	0.000184	CbGpPWpGaD
Cyclosporine—CYP2C8—Biological oxidations—POMC—multiple sclerosis	2.07e-05	0.000183	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—TYK2—multiple sclerosis	2.06e-05	0.000183	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—CD80—multiple sclerosis	2.06e-05	0.000183	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—MAPK1—multiple sclerosis	2.06e-05	0.000183	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—RPL5—multiple sclerosis	2.05e-05	0.000181	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—SRM—multiple sclerosis	1.99e-05	0.000177	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CD86—multiple sclerosis	1.98e-05	0.000176	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—SLC11A1—multiple sclerosis	1.96e-05	0.000174	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CNR1—multiple sclerosis	1.95e-05	0.000173	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CCL5—multiple sclerosis	1.95e-05	0.000173	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—CCR5—multiple sclerosis	1.94e-05	0.000172	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—SRM—multiple sclerosis	1.94e-05	0.000172	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	1.94e-05	0.000172	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.94e-05	0.000172	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—RRM1—multiple sclerosis	1.92e-05	0.00017	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—RRM1—multiple sclerosis	1.9e-05	0.000169	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—HLA-A—multiple sclerosis	1.9e-05	0.000168	CbGpPWpGaD
Cyclosporine—PPIA—Disease—CD4—multiple sclerosis	1.9e-05	0.000168	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—TYK2—multiple sclerosis	1.89e-05	0.000167	CbGpPWpGaD
Cyclosporine—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	1.88e-05	0.000167	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.88e-05	0.000167	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.86e-05	0.000165	CbGpPWpGaD
Cyclosporine—CYP2C19—Biological oxidations—POMC—multiple sclerosis	1.85e-05	0.000164	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—SRM—multiple sclerosis	1.83e-05	0.000163	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—SRM—multiple sclerosis	1.82e-05	0.000161	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	1.82e-05	0.000161	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	1.82e-05	0.000161	CbGpPWpGaD
Cyclosporine—ABCB1—Allograft Rejection—TNF—multiple sclerosis	1.81e-05	0.00016	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—SPP1—multiple sclerosis	1.81e-05	0.00016	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—APOE—multiple sclerosis	1.77e-05	0.000157	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—IFNG—multiple sclerosis	1.77e-05	0.000157	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.77e-05	0.000157	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CCR5—multiple sclerosis	1.76e-05	0.000156	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CXCL10—multiple sclerosis	1.76e-05	0.000156	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—TYK2—multiple sclerosis	1.74e-05	0.000154	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—IL2RA—multiple sclerosis	1.73e-05	0.000154	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—IL2—multiple sclerosis	1.72e-05	0.000152	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—CD4—multiple sclerosis	1.71e-05	0.000151	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—APOE—multiple sclerosis	1.7e-05	0.000151	CbGpPWpGaD
Cyclosporine—CYP2D6—Biological oxidations—POMC—multiple sclerosis	1.7e-05	0.000151	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.69e-05	0.00015	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.69e-05	0.00015	CbGpPWpGaD
Cyclosporine—CYP2C9—Biological oxidations—POMC—multiple sclerosis	1.68e-05	0.000149	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—BCHE—multiple sclerosis	1.67e-05	0.000148	CbGpPWpGaD
Cyclosporine—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.67e-05	0.000148	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—GPC5—multiple sclerosis	1.66e-05	0.000147	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.62e-05	0.000143	CbGpPWpGaD
Cyclosporine—ABCC3—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.61e-05	0.000143	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.61e-05	0.000143	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—BCHE—multiple sclerosis	1.6e-05	0.000142	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—CD80—multiple sclerosis	1.6e-05	0.000142	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—APOE—multiple sclerosis	1.6e-05	0.000142	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—IL6—multiple sclerosis	1.58e-05	0.00014	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—IL1B—multiple sclerosis	1.58e-05	0.00014	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—CD4—multiple sclerosis	1.58e-05	0.00014	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	1.57e-05	0.000139	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	1.57e-05	0.000139	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—IL2—multiple sclerosis	1.57e-05	0.000139	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CD28—multiple sclerosis	1.56e-05	0.000139	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.54e-05	0.000136	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CD86—multiple sclerosis	1.54e-05	0.000136	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CCL5—multiple sclerosis	1.51e-05	0.000134	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.47e-05	0.000131	CbGpPWpGaD
Cyclosporine—PPIA—Disease—STAT3—multiple sclerosis	1.47e-05	0.00013	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—POMC—multiple sclerosis	1.46e-05	0.00013	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.45e-05	0.000129	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CD80—multiple sclerosis	1.44e-05	0.000128	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—GPC5—multiple sclerosis	1.44e-05	0.000128	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.4e-05	0.000124	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.4e-05	0.000124	CbGpPWpGaD
Cyclosporine—SLCO1A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.4e-05	0.000124	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—SPP1—multiple sclerosis	1.4e-05	0.000124	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—BCHE—multiple sclerosis	1.39e-05	0.000124	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.38e-05	0.000123	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—RRM1—multiple sclerosis	1.38e-05	0.000122	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—POMC—multiple sclerosis	1.37e-05	0.000122	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.37e-05	0.000122	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CYP27B1—multiple sclerosis	1.37e-05	0.000122	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CYP24A1—multiple sclerosis	1.37e-05	0.000122	CbGpPWpGaD
Cyclosporine—PPIA—Disease—MYC—multiple sclerosis	1.36e-05	0.000121	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CCR5—multiple sclerosis	1.36e-05	0.000121	CbGpPWpGaD
Cyclosporine—PPIA—Disease—TGFB1—multiple sclerosis	1.36e-05	0.000121	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—TYK2—multiple sclerosis	1.35e-05	0.00012	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—CCL2—multiple sclerosis	1.34e-05	0.000119	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IL2RA—multiple sclerosis	1.34e-05	0.000119	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—ALB—multiple sclerosis	1.33e-05	0.000118	CbGpPWpGaD
Cyclosporine—PPIA—Disease—MAPK1—multiple sclerosis	1.33e-05	0.000118	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.33e-05	0.000118	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—STAT3—multiple sclerosis	1.32e-05	0.000117	CbGpPWpGaD
Cyclosporine—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.32e-05	0.000117	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—MAPK1—multiple sclerosis	1.31e-05	0.000117	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	1.29e-05	0.000114	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	1.29e-05	0.000114	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—GPC5—multiple sclerosis	1.28e-05	0.000114	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.28e-05	0.000114	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.28e-05	0.000114	CbGpPWpGaD
Cyclosporine—ABCC2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.28e-05	0.000113	CbGpPWpGaD
Cyclosporine—ABCC1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.26e-05	0.000112	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.26e-05	0.000112	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—BCHE—multiple sclerosis	1.25e-05	0.000111	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—GPC5—multiple sclerosis	1.25e-05	0.000111	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.25e-05	0.000111	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—APOE—multiple sclerosis	1.24e-05	0.00011	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—CD4—multiple sclerosis	1.22e-05	0.000108	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—TYK2—multiple sclerosis	1.22e-05	0.000108	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—STAT3—multiple sclerosis	1.22e-05	0.000108	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—MAPK1—multiple sclerosis	1.2e-05	0.000106	CbGpPWpGaD
Cyclosporine—SLCO1B1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.2e-05	0.000106	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—SRM—multiple sclerosis	1.2e-05	0.000106	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—RRM1—multiple sclerosis	1.19e-05	0.000106	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—BCHE—multiple sclerosis	1.19e-05	0.000106	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—GPC5—multiple sclerosis	1.18e-05	0.000105	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.17e-05	0.000104	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—MYC—multiple sclerosis	1.13e-05	0.0001	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—TGFB1—multiple sclerosis	1.13e-05	0.0001	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CD80—multiple sclerosis	1.12e-05	9.93e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CD86—multiple sclerosis	1.12e-05	9.9e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.11e-05	9.85e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.11e-05	9.84e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—MAPK1—multiple sclerosis	1.11e-05	9.83e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—BCHE—multiple sclerosis	1.1e-05	9.78e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—BCHE—multiple sclerosis	1.09e-05	9.7e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—POMC—multiple sclerosis	1.06e-05	9.44e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.06e-05	9.43e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—CCL2—multiple sclerosis	1.04e-05	9.24e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—RRM1—multiple sclerosis	1.04e-05	9.21e-05	CbGpPWpGaD
Cyclosporine—PPIA—Disease—IL6—multiple sclerosis	1.02e-05	9.09e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—IL2—multiple sclerosis	1.01e-05	9e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—IL6—multiple sclerosis	1.01e-05	8.95e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—APOE—multiple sclerosis	1e-05	8.9e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CCR5—multiple sclerosis	9.9e-06	8.78e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—RRM1—multiple sclerosis	9.78e-06	8.68e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—RRM1—multiple sclerosis	9.7e-06	8.6e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—HLA-A—multiple sclerosis	9.65e-06	8.55e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—APOE—multiple sclerosis	9.62e-06	8.53e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—MMP9—multiple sclerosis	9.6e-06	8.52e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	9.58e-06	8.5e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	9.56e-06	8.48e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TYK2—multiple sclerosis	9.46e-06	8.39e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—STAT3—multiple sclerosis	9.46e-06	8.39e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	9.37e-06	8.31e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	9.25e-06	8.2e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—IL6—multiple sclerosis	9.23e-06	8.18e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—APOE—multiple sclerosis	9e-06	7.99e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	8.92e-06	7.91e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—MYC—multiple sclerosis	8.79e-06	7.79e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—TGFB1—multiple sclerosis	8.76e-06	7.77e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—POMC—multiple sclerosis	8.62e-06	7.65e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—MAPK1—multiple sclerosis	8.6e-06	7.62e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—STAT3—multiple sclerosis	8.54e-06	7.57e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—IL6—multiple sclerosis	8.52e-06	7.55e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	8.44e-06	7.49e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	8.44e-06	7.49e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—APOE—multiple sclerosis	8.38e-06	7.43e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—POMC—multiple sclerosis	8.27e-06	7.33e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.25e-06	7.32e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CD80—multiple sclerosis	8.14e-06	7.22e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.94e-06	7.04e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—MYC—multiple sclerosis	7.94e-06	7.04e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—TGFB1—multiple sclerosis	7.92e-06	7.02e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—BCHE—multiple sclerosis	7.9e-06	7.01e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IL2—multiple sclerosis	7.87e-06	6.98e-05	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—ALB—multiple sclerosis	7.86e-06	6.97e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—MAPK1—multiple sclerosis	7.76e-06	6.88e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—GPC5—multiple sclerosis	7.72e-06	6.85e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—APOE—multiple sclerosis	7.54e-06	6.69e-05	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—ALB—multiple sclerosis	7.54e-06	6.68e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.53e-06	6.67e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MMP9—multiple sclerosis	7.45e-06	6.6e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	7.24e-06	6.42e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—POMC—multiple sclerosis	7.2e-06	6.38e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—APOE—multiple sclerosis	7.17e-06	6.36e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.09e-06	6.29e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—TYK2—multiple sclerosis	6.87e-06	6.09e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—BCHE—multiple sclerosis	6.85e-06	6.07e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—APOE—multiple sclerosis	6.64e-06	5.88e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—STAT3—multiple sclerosis	6.62e-06	5.87e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—IL6—multiple sclerosis	6.6e-06	5.86e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—APOE—multiple sclerosis	6.58e-06	5.83e-05	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—ALB—multiple sclerosis	6.56e-06	5.82e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—POMC—multiple sclerosis	6.48e-06	5.75e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.46e-06	5.73e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.46e-06	5.73e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—RRM1—multiple sclerosis	6.4e-06	5.67e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CD4—multiple sclerosis	6.22e-06	5.51e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—POMC—multiple sclerosis	6.16e-06	5.46e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MYC—multiple sclerosis	6.15e-06	5.46e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TGFB1—multiple sclerosis	6.14e-06	5.44e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—BCHE—multiple sclerosis	6.11e-06	5.42e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MAPK1—multiple sclerosis	6.02e-06	5.34e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	6e-06	5.32e-05	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—IL6—multiple sclerosis	5.96e-06	5.29e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—BCHE—multiple sclerosis	5.96e-06	5.29e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—ALB—multiple sclerosis	5.91e-06	5.24e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.89e-06	5.23e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—POMC—multiple sclerosis	5.7e-06	5.06e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—POMC—multiple sclerosis	5.65e-06	5.01e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—BCHE—multiple sclerosis	5.62e-06	4.98e-05	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—ALB—multiple sclerosis	5.61e-06	4.98e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—BCHE—multiple sclerosis	5.57e-06	4.94e-05	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—ALB—multiple sclerosis	5.2e-06	4.61e-05	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—ALB—multiple sclerosis	5.15e-06	4.57e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—STAT3—multiple sclerosis	4.81e-06	4.27e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—APOE—multiple sclerosis	4.75e-06	4.22e-05	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IL6—multiple sclerosis	4.63e-06	4.1e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MYC—multiple sclerosis	4.47e-06	3.97e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—TGFB1—multiple sclerosis	4.46e-06	3.96e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—MAPK1—multiple sclerosis	4.37e-06	3.88e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—APOE—multiple sclerosis	4.12e-06	3.65e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—POMC—multiple sclerosis	4.08e-06	3.62e-05	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—ALB—multiple sclerosis	3.72e-06	3.3e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—APOE—multiple sclerosis	3.68e-06	3.26e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—BCHE—multiple sclerosis	3.67e-06	3.26e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—APOE—multiple sclerosis	3.59e-06	3.18e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—POMC—multiple sclerosis	3.54e-06	3.14e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—APOE—multiple sclerosis	3.38e-06	3e-05	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—IL6—multiple sclerosis	3.36e-06	2.98e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—APOE—multiple sclerosis	3.35e-06	2.97e-05	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ALB—multiple sclerosis	3.23e-06	2.86e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—POMC—multiple sclerosis	3.16e-06	2.8e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—POMC—multiple sclerosis	3.08e-06	2.73e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—POMC—multiple sclerosis	2.9e-06	2.58e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—POMC—multiple sclerosis	2.88e-06	2.55e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ALB—multiple sclerosis	2.88e-06	2.55e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—ALB—multiple sclerosis	2.81e-06	2.49e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ALB—multiple sclerosis	2.65e-06	2.35e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ALB—multiple sclerosis	2.62e-06	2.33e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—APOE—multiple sclerosis	2.21e-06	1.96e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—POMC—multiple sclerosis	1.9e-06	1.68e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ALB—multiple sclerosis	1.73e-06	1.54e-05	CbGpPWpGaD
